Impact of Post Manufacturing Handling of Protein-Based Biologic Drugs on Product Quality and User Centricity基于蛋白质的生物药物的制造后处理对产品质量和以用户为中心的影响JOURNAL OF PHARMACEUTICAL SCIENCESIF3.82024-08-013OAAI
Use of Closed System Transfer Devices (CSTDs) with ProteinBased Therapeutic Drugs-A Non-Solution for a Non-Problem?JOURNAL OF PHARMACEUTICAL SCIENCESIF3.82024-02-012PRE
Current Industry Best Practice on in-use Stability and Compatibility Studies for Biological ProductsJOURNAL OF PHARMACEUTICAL SCIENCESIF3.82023-09-0115PRE
Correction: End-to-End Approach to Surfactant Selection, Risk Mitigation, and Control Strategies for Protein-Based Therapeutics(vol 25, 6, 2023)AAPS JOURNALIF3.72023-01-111OA
End-to-End Approach to Surfactant Selection, Risk Mitigation, and Control Strategies for Protein-Based TherapeuticsAAPS JOURNALIF3.72022-12-058PRE
Carbohydrate groups of α1-microglobulin are important for secretion and tissue localization but not for immunological propertiesGLYCOBIOLOGYIF3.32000-09-0127OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向